Infiheal Gains Ethical Approval for Pilot Study with AIIMS
We are proud to share an important milestone for Infiheal.
Our collaborative pilot study with the National Centre for Assistive Health Technology (NCAHT), at AIIMS Delhi and funded by ICMR has received ethical approval. This marks the beginning of an exciting step in evaluating the impact of our flagship product, Healo, in supporting mental healthcare.
The study, titled "Evaluating the Effectiveness of a Chatbot in Improving Anxiety Symptoms Amongst Patients Attending Psychiatric Services at a Tertiary Care Centre: A Randomised Controlled Trial," will explore how an AI-powered chatbot can support individuals experiencing anxiety within a clinical setting.
We are grateful to Dr. Salaj Rana, Dr. Rajesh Sagar, Dr Rahul Mathur, Dr Manu Sharma, and Dr. Nishtha Chawla for their guidance and collaboration in bringing this research to life.
At Infiheal, we believe that meaningful innovation in mental health must be grounded in evidence, ethics, and collaboration. Receiving ethical approval is an important milestone that reinforces our commitment to developing solutions that are not only innovative but also clinically evaluated and responsibly designed.
We look forward to contributing to the growing body of evidence supporting technology-enabled mental healthcare.
